About this trial
Low Excision and High Suspension Hemorrhoidectomy versus Conventional Milligan-Morgan Hemorrhoidectomy for Mixed Hemorrhoids
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with Goligher grade III-IV mixed hemorrhoids via anorectal examination;
Failed conservative treatment for at least 3 months;
Voluntarily participated in the study and agreed to complete the 12-month follow-up.
Disqualifiers
History of previous anorectal surgery;
Severe coagulation dysfunction, cardiopulmonary insufficiency, hepatic/renal failure, or mental disorders;
Pregnancy or lactation;
Inability to cooperate with postoperative follow-up and evaluation.
Trial design
Parallel
Treatments tested in this trial
Low Excision and High Suspension Hemorrhoidectomy
Procedure/SurgeryLow Excision and High Suspension Hemorrhoidectomy
Conventional Milligan-Morgan Hemorrhoidectomy
Procedure/SurgeryConventional Milligan-Morgan Hemorrhoidectomy
Treatment groups
Trial outcomes
Primary outcomes
Clinical effective rate at 12 weeks postoperatively
Cured (complete resolution of symptoms and hemorrhoid prolapse) + improved (obvious relief of clinical symptoms) / total number of patients; an effective rate ≥90% was defined as clinically effective.
Hemorrhoid recurrence rate at 12 months postoperatively
Recurrence was defined as the reappearance of hemorrhoid prolapse or rectal bleeding requiring clinical reintervention during the follow-up period.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: